Moreover, we found some known stemness‐related genes among the top 50 genes representing the stemness programme, such as the transcription factor GATA3, which has been identified as a robust predictor of clinical outcome in human luminal breast cancer. This evidence concerns the gene GATA3 and breast cancer.